SAN DIEGO--(BUSINESS WIRE)--Aug. 9, 2006--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (the “Company” or “Ligand”) announced unaudited financial results for its second quarter of fiscal year 2006.
SAN DIEGO--(BUSINESS WIRE)--Aug. 9, 2006--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (the “Company” or “Ligand”) announced unaudited financial results for its second quarter of fiscal year 2006.